儿科创伤性脑损伤:独特的人口和独特的挑战
Shruti Agrawal1,2, Rebekah Mannix3, Vicki Anderson4
1Paediatric Intensive Care, Department of Paediatrics, Cambridge University Hospitals, Cambridge, CB2 0QQ, UK.
Brain : a journal of neurology
|December 13, 2025
概括
儿童创伤性脑损伤 (pTBI) 管理需要更多的证据,因为目前的方法落后于成人护理. 未来的研究应该专注于生物标志物和干预措施,以改善pTBI儿童的结果.
科学领域:
- 儿科神经学 儿科神经学
- 神经创伤是一种神经创伤.
- 儿童健康研究 儿童健康研究
背景情况:
- 儿童创伤性脑损伤 (pTBI) 是全球儿童死亡和残疾的主要原因.
- 与成人人口相比,儿童的pTBI管理策略缺乏强有力的证据.
- 儿童的发育变异对于pTBI诊断和治疗具有独特的挑战.
研究的目的:
- 综合最近关于儿童pTBI的发现.
- 评估现有证据,并确定管理和治疗策略中的差距.
- 建议未来的研究方向,以改善pTBI的结果.
主要方法:
- 对儿科人口的流行病学和病理生理学差异的审查.
- 评估生理学,血液和成像生物标志物用于诊断和预后.
- 分析当前的治疗策略,康复和护理系统.
主要成果:
- 在了解pTBI机制,病理生理学和恢复途径方面取得的进展是渐进的.
- 生物标志物研究显示了改善诊断和结果预测的前景.
- 在将研究转化为有效的干预措施方面,仍然存在显著的证据差距.
结论:
- 进一步的研究对于解决儿科创伤性脑损伤的证据缺口至关重要.
- 需要制定有针对性的干预措施和改善护理系统.
- 生物标志物的发现和验证是推动临床决策和患者结果的关键.
相关概念视频
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
229
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
229
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
240
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
240